Tag: Patient Safety

FDA: Hospira recalls another lot of Propofol

Editor's Note The Food and Drug Administration (FDA) on August 22 posted the Hospira Inc (a Pfizer company) recall of one lot of Propofol Injectable Emulsion (containing Benzyl alcohol), 100 mL single patient use glass fliptop vials, lot EA7470. The recall was initiated because of visible particulates observed in two…

Read More

By: Judy Mathias
August 23, 2022
Share

FDA: Class I recall of Medtronic Cobalt/Crome ICDs, CRT-Ds

Editor's Note The Food and Drug Administration (FDA) on August 19 identified the recall by Medtronic of its Cobalt XT, Cobalt, and Crome Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) as Class I, the most serious. The devices are being recalled because of reports of short circuit-protection…

Read More

By: Judy Mathias
August 22, 2022
Share

Unprofessional behavior improved with just a cup of coffee

What if unprofessional behavior in the OR could be managed through something as simple as an informal chat over a cup of coffee? This peer-to-peer approach advocated by Vanderbilt University School of Medicine led to the development of two well-established, scientifically validated programs designed to offset unprofessional behavior: the Patient…

Read More

By: Brita Belli
August 19, 2022
Share

Study: More than half unaware of Omicron infection status

Editor's Note This study led by researchers at Cedars-Sinai Medical Center, Los Angeles, finds that more than half of adults with recent Omicron infection analyzed were unaware of their infectious status. Of 210 adult employees or patients at Cedars-Sinai Medical Center with serological evidence of recent Omicron variant infection: 92…

Read More

By: Judy Mathias
August 18, 2022
Share

Timing of major surgery after COVID-19 affects postop mortality

Editor's Note This study led by researchers at State University of New York Downstate Health Sciences University, Brooklyn, finds that patients having major surgical procedures within 8 weeks of a COVID-19 infection have a substantially higher postoperative 90-day mortality, regardless of symptoms. Analyzing data on 938 COVID-19 positive patient cases…

Read More

By: Judy Mathias
August 17, 2022
Share

Maternal morbidity associated with delivery during COVID-19

Editor's Note This retrospective cohort study led by researchers at Ascension Health, St Louis, finds that COVID-19 infection is a risk factor for adverse peripartum maternal outcomes. Researchers evaluated the association of COVID-19 with severe maternal morbidities in patients delivering during four pandemic periods characterized by predominant variants—March-December 2020 (wild…

Read More

By: Judy Mathias
August 15, 2022
Share

FDA: Class I recall of BD Intraosseous Infusion System

Editor's Note The Food and Drug Administration (FDA) on August 11 classified the recall by Becton Dickinson (BD) of its Intraosseous Infusion System, which includes Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits, and Intraosseous Powered Drivers, as Class I, the most serious. The recall was initiated for three separate…

Read More

By: Judy Mathias
August 11, 2022
Share

Recovery of smell, taste after COVID-19 may take 6 months

Editor's Note This meta-analysis led by researchers at the National University of Singapore finds that recovery of the ability to taste and smell after COVID-19 infection may take up to 6 months, and women are more likely to experience loss of these senses and have a longer time to recovery.…

Read More

By: Judy Mathias
August 10, 2022
Share

FDA: Class I recall of Haimen Shengbang Viral Transport Media Containers

Editor's Note The Food and Drug Administration (FDA) on August 9 identified the recall by Haimen Shengbang Laboratory Equipment Co Ltd of its Viral Transport Media Containers as Class I, the most serious. The recall was initiated because the products were distributed in the US without authorization, clearance, or approval…

Read More

By: Judy Mathias
August 10, 2022
Share

Disparities in US COVID-19 vaccine distribution

Editor's Note This study led by researchers at the University of California, San Diego, finds that healthcare facilities in counties with higher Black composition and rural areas with large Hispanic populations were less likely to serve as COVID-19 vaccine administration locations during the initial rollout in May 2021. At that…

Read More

By: Judy Mathias
August 9, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat